AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 132 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,000 | +120.0% | 739 | +5.6% | 0.00% | – |
| Q2 2022 | $5,000 | -97.6% | 700 | -96.9% | 0.00% | -100.0% |
| Q1 2022 | $207,000 | +4040.0% | 22,700 | +3142.9% | 0.00% | – |
| Q4 2021 | $5,000 | -94.9% | 700 | -91.8% | 0.00% | -100.0% |
| Q3 2021 | $98,000 | +790.9% | 8,583 | +1126.1% | 0.00% | – |
| Q2 2021 | $11,000 | -15.4% | 700 | 0.0% | 0.00% | – |
| Q1 2021 | $13,000 | +44.4% | 700 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | -89.2% | 700 | -90.1% | 0.00% | -100.0% |
| Q3 2020 | $83,000 | +1560.0% | 7,047 | +1913.4% | 0.00% | – |
| Q2 2020 | $5,000 | -72.2% | 350 | -73.1% | 0.00% | – |
| Q1 2020 | $18,000 | -35.7% | 1,300 | +12.1% | 0.00% | – |
| Q4 2019 | $28,000 | -84.4% | 1,160 | -87.6% | 0.00% | -100.0% |
| Q3 2019 | $180,000 | +2900.0% | 9,340 | +4347.6% | 0.00% | – |
| Q2 2019 | $6,000 | -40.0% | 210 | 0.0% | 0.00% | – |
| Q1 2019 | $10,000 | +25.0% | 210 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -38.5% | 210 | 0.0% | 0.00% | – |
| Q3 2018 | $13,000 | -7.1% | 210 | 0.0% | 0.00% | – |
| Q2 2018 | $14,000 | +27.3% | 210 | 0.0% | 0.00% | – |
| Q1 2018 | $11,000 | -31.2% | 210 | -19.2% | 0.00% | – |
| Q4 2017 | $16,000 | +23.1% | 260 | 0.0% | 0.00% | – |
| Q3 2017 | $13,000 | -7.1% | 260 | 0.0% | 0.00% | – |
| Q2 2017 | $14,000 | +100.0% | 260 | +62.5% | 0.00% | – |
| Q1 2017 | $7,000 | -36.4% | 160 | -46.7% | 0.00% | – |
| Q4 2016 | $11,000 | -52.2% | 300 | -50.0% | 0.00% | – |
| Q3 2016 | $23,000 | +109.1% | 600 | 0.0% | 0.00% | – |
| Q2 2016 | $11,000 | +57.1% | 600 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |